The seroprevalence and kinetics of IgM and IgG in the progression of COVID-19
Abstract Background SARS-CoV-2 is a novel coronavirus first recognized in late December 2019 that causes coronavirus disease 19 (COVID-19). Due to the highly contagious nature of SARS-CoV-2, it has developed into a global pandemic in just a few months. Antibody testing is an effective method to supp...
Gardado en:
| Principais autores: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMC
2021-02-01
|
| Series: | BMC Immunology |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1186/s12865-021-00404-0 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|